BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 3)

COVID-19: FDA broadens EUA for remdesivir

By

As part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration today broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to...

COVID-19

COVID-19: FDA issues EUA for convalescent plasma as potential treatment

By

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) today for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the...

Oleandrin dangers: Toxicology Organization’s joint statement concerning proposals for the use as a potential treatment for COVID-19

By

The American College of Medical Toxicology (ACMT), the American Academy of Clinical Toxicology (AACT), and the American Association of Poison Control Centers has issued the following joint statement in...

COVID-19

COVID-19 treatment: Gilead submits New Drug Application to FDA for Remdesivir

By

Gilead Sciences, Inc. announced Monday that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Veklury® (remdesivir), an investigational antiviral for the...

Chagas disease treatment, Lampit, receives FDA approval for use in children

By

Bayer announced today that the United States Food and Drug Administration (FDA) has approved Lampit® (nifurtimox) for use in pediatric patients (from birth to less than 18 years of age and weighing at...

Hepatitis D drug, Hepcludex, receives approval by the European Commission

By

What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers...

Neisseria meningitidis antibiotic resistance case raises serious concerns

By

A recent meningitis case at Children’s National Hospital raises serious concerns about antibiotic resistance in the common bacterium that caused it, researchers from the hospital write in a case...

Chloroquine doesn’t prevent the spread of SARS-CoV-2 in the lungs, Should not be used for the treatment of COVID-19: Researchers

By

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2). In order to obtain an effective therapy for COVID-19 as...

Yellow fever: Experimental monoclonal antibody shows success in early-stage clinical trials in Singapore

By

Yellow fever, a hemorrhagic disease that is common in South America and sub-Saharan Africa, infects about 200,000 people per year and causes an estimated 30,000 deaths. While there is a vaccine for yellow...

Phase 2/3 clinical trial for critically ill COVID-19 patients continues to enroll patients as cases surge across the country

By

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holdings AG today announced that the independent Data Monitoring Committee has reviewed the findings in the first 30 patients treated in Fast Track...